Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU J.K. Yamamoto-Furusho; D. Andrade; J. Barahona; S. Bautista; F. Bosques-Padilla; J. de Paula; M.T. Galiano; B. Iade; F. Juliao-Baños; G. Otoya; F. Steinwurz; E. Torres; G. Veitia; M. Barreiro-de Acosta;

ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease A. Jena; N. Grover; P. Bhatia; M. Singh; D. Lad; K.K. Prasad; H. Singh; U. Dutta; V. Sharma;

A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center K.A. El-Atrebi; E. Taher; F.H. El Aguizy; R.M. Ali; A. Hegazy; M.M. El-Sayed; B. Eysa; A.A. El-Atreby; A.A. Mohammed; H.T. El-Bassyouni;